Home LiteratureArticle Details
PMID: 12832473 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner.

Molecular and cellular biology ·Vol. 23 ·No. 14 ·2003-07-00 ·Pages 4870-81

Sorci G, Riuzzi F, Agneletti AL, Marchetti C, Donato R

Abstract

S100B is a Ca(2+)-modulated protein of the EF-hand type with both intracellular and extracellular roles. S100B, which is most abundant in the brain, has been shown to exert trophic and toxic effects on neurons depending on the concentration attained in the extracellular space. S100B is also found in normal serum, and its serum concentration increases in several nervous and nonnervous pathological conditions, suggesting that S100B-expressing cells outside the brain might release the protein and S100B might exert effects on nonnervous cells. We show here that at picomolar to nanomolar levels, S100B inhibits myogenic differentiation of rat L6 myoblasts via inactivation of p38 kinase with resulting decrease in the expression of the myogenic differentiation markers, myogenin, muscle creatine kinase, and myosin heavy chain, and reduction of myotube formation. Although myoblasts express the multiligand receptor RAGE, which has been shown to transduce S100B effects on neurons, S100B produces identical effects on myoblasts overexpressing either full-length RAGE or RAGE lacking the transducing domain. This suggests that S100B affects myoblasts by interacting with another receptor and that RAGE is not the only receptor for S100B. Our data suggest that S100B might participate in the regulation of muscle development and regeneration by inhibiting crucial steps of the myogenic program in a RAGE-independent manner.

MeSH Terms
Animals Biomarkers/analysis Cell Differentiation/drug effects Cells, Cultured Creatine Kinase/drug effects,metabolism Dose-Response Relationship, Drug Enzyme Activation/drug effects Mitogen-Activated Protein Kinases/antagonists & inhibitors,metabolism Muscle Fibers, Skeletal/cytology,drug effects,physiology Mutation Myoblasts, Skeletal/cytology,drug effects Myogenin/drug effects,metabolism Myosin Heavy Chains/drug effects,metabolism Nerve Growth Factors/pharmacology,physiology Rats Receptor for Advanced Glycation End Products Receptors, Immunologic/genetics,metabolism S100 Calcium Binding Protein beta Subunit S100 Proteins/pharmacology,physiology p38 Mitogen-Activated Protein Kinases
Chemicals
Biomarkers Myog protein, rat Myogenin Nerve Growth Factors Receptor for Advanced Glycation End Products Receptors, Immunologic S100 Calcium Binding Protein beta Subunit S100 Proteins S100b protein, rat Mitogen-Activated Protein Kinases p38 Mitogen-Activated Protein Kinases Creatine Kinase Myosin Heavy Chains
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sorci Guglielmo
Section of Anatomy, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, 06122 Perugia, Italy.
Riuzzi Francesca
Agneletti Anna Lisa
Marchetti Cristina
Donato Rosario
References (49)
49 references, click to expand
  1. Replicating myoblasts and fused myotubes express the calcium-regulated proteins S100A1 and S100B.
    Cell Calcium. 1999 Feb;25(2):93-106 PMID: 10326676
  2. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.
    J Neurosci Res. 1994 Nov 1;39(4):398-404 PMID: 7884819
  3. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type.
    Biochim Biophys Acta. 1999 Jul 8;1450(3):191-231 PMID: 10395934
  4. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes.
    Glia. 1999 Sep;27(3):275-81 PMID: 10457374
  5. Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB.
    FASEB J. 1999 Sep;13(12):1611-20 PMID: 10463953
  6. S100beta induction of the proinflammatory cytokine interleukin-6 in neurons.
    J Neurochem. 2000 Jan;74(1):143-50 PMID: 10617115
  7. S100 beta protects hippocampal neurons from damage induced by glucose deprivation.
    Brain Res. 1995 Apr 17;677(1):167-70 PMID: 7606463
  8. Transcription factor families: muscling in on the myogenic program.
    FASEB J. 1995 Dec;9(15):1595-604 PMID: 8529839
  9. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes.
    J Biol Chem. 1996 Feb 2;271(5):2543-7 PMID: 8576219
  10. The S100 family of EF-hand calcium-binding proteins: functions and pathology.
    Trends Biochem Sci. 1996 Apr;21(4):134-40 PMID: 8701470
  11. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta).
    J Biol Chem. 1996 Jul 26;271(30):17920-6 PMID: 8663524
  12. beta-Amyloid regulates gene expression of glial trophic substance S100 beta in C6 glioma and primary astrocyte cultures.
    Brain Res Mol Brain Res. 1995 Dec 1;34(1):118-26 PMID: 8750867
  13. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke.
    J Neurol Sci. 1997 May 1;148(1):101-5 PMID: 9125396
  14. S-100beta stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants.
    Brain Res. 1997 Apr 11;753(2):196-201 PMID: 9125403
  15. S-100 protein release in a range of cardiothoracic surgical procedures.
    J Thorac Cardiovasc Surg. 1997 May;113(5):953-4 PMID: 9159632
  16. S100 beta prevents the death of motor neurons in newborn rats after sciatic nerve section.
    J Neurol Sci. 1997 Oct 3;151(1):7-12 PMID: 9335003
  17. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.
    Stroke. 1997 Oct;28(10):1961-5 PMID: 9341704
  18. S100beta induces neuronal cell death through nitric oxide release from astrocytes.
    J Neurochem. 1997 Dec;69(6):2294-301 PMID: 9375660
  19. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest.
    Stroke. 1998 Feb;29(2):473-7 PMID: 9472892
  20. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study.
    BMJ. 1998 Feb 21;316(7131):577-82 PMID: 9518907
  21. S-100 serum levels after minor and major head injury.
    J Trauma. 1998 Oct;45(4):765-7 PMID: 9783618
  22. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis.
    J Biol Chem. 1999 Feb 12;274(7):4341-6 PMID: 9933636
  23. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor.
    J Biol Chem. 1999 Feb 19;274(8):5193-200 PMID: 9988769
  24. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice.
    J Neurochem. 2000 Jan;74(1):295-301 PMID: 10617132
  25. Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures.
    Brain Res. 2000 Jan 17;853(1):74-80 PMID: 10627310
  26. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702.
    Brain Res. 2000 Mar 6;858(1):121-8 PMID: 10700604
  27. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells.
    Genes Dev. 2000 Mar 1;14(5):574-84 PMID: 10716945
  28. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.
    Mol Cell Biol. 2000 Jun;20(11):3951-64 PMID: 10805738
  29. Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation.
    J Biol Chem. 2000 Nov 3;275(44):34424-32 PMID: 10896679
  30. The biology of the receptor for advanced glycation end products and its ligands.
    Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111 PMID: 11108954
  31. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
    J Biol Chem. 2000 Dec 22;275(51):40096-105 PMID: 11007787
  32. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology.
    FEBS Lett. 2000 Dec 15;486(3):203-7 PMID: 11119704
  33. S100B expression in and effects on microglia.
    Glia. 2001 Feb;33(2):131-42 PMID: 11180510
  34. Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma.
    J Clin Oncol. 2001 Feb 1;19(3):824-31 PMID: 11157036
  35. High serum S100B levels for trauma patients without head injuries.
    Neurosurgery. 2001 Jun;48(6):1255-8; discussion 1258-60 PMID: 11383727
  36. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.
    Int J Biochem Cell Biol. 2001 Jul;33(7):637-68 PMID: 11390274
  37. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles.
    Neuroscience. 2002;109(2):371-88 PMID: 11801372
  38. Hormonal regulation of adipose S-100 protein release.
    J Neurochem. 1984 Nov;43(5):1336-41 PMID: 6092538
  39. Purification and characterization of a neurite extension factor from bovine brain.
    Proc Natl Acad Sci U S A. 1985 Oct;82(20):7136-9 PMID: 3863143
  40. Calcium-independent, pH-regulated effects of S-100 proteins on assembly-disassembly of brain microtubule protein in vitro.
    J Biol Chem. 1988 Jan 5;263(1):106-10 PMID: 3335493
  41. Secretion of S-100 from rat C6 glioma cells.
    Brain Res. 1987 Dec 15;436(2):367-70 PMID: 3435834
  42. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
    Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5 PMID: 2529544
  43. Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues.
    J Cell Biol. 1989 Dec;109(6 Pt 1):3063-71 PMID: 2592414
  44. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology.
    Brain Res. 1990 Sep 24;528(1):155-8 PMID: 2245332
  45. Neurotrophic protein S100 beta stimulates glial cell proliferation.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3554-8 PMID: 1902567
  46. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo.
    J Neurobiol. 1992 Jun;23(4):451-66 PMID: 1634890
  47. The brain protein S-100ab induces apoptosis in PC12 cells.
    Neuroscience. 1994 May;60(1):29-35 PMID: 7519760
  48. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.
    Arterioscler Thromb. 1994 Oct;14(10):1521-8 PMID: 7918300
  49. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.
    Cell. 1999 Jun 25;97(7):889-901 PMID: 10399917
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2003-07-00
Pages
4870-81
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC162222
Subset
IM
Grants
Telethon · 922 · Italy
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com